PRIME-XV T Cell CDM
PRIME-XV™ T Cell CDM is a chemically defined medium developed to support T cell culture, activation, expansion, and manufacturing workflows. Designed for cell therapy applications, it provides a serum-free, animal component-free platform that promotes consistent T cell growth while supporting scalable development and production processes.
Place your order directly with the manufacturer.
PRIME-XV™ T Cell CDM is a chemically defined medium formulated to support the culture and expansion of T cells for research, process development, and cell therapy applications. The medium is part of the PRIME-XV portfolio, which was developed to provide researchers and manufacturers with serum-free, controlled culture systems that help improve consistency and reduce variability.
The chemically defined formulation eliminates animal-derived components and supports reproducible T cell culture conditions. This makes PRIME-XV T Cell CDM well-suited for workflows requiring a high level of process control and consistency, including immunotherapy development and cell therapy manufacturing.
Designed to support scalable workflows, PRIME-XV T Cell CDM can be incorporated into T cell expansion and production strategies from early-stage research through advanced development programs. Its defined composition helps facilitate standardization across laboratories and manufacturing environments.
Key Features & Benefits
- Chemically defined T cell culture medium
- Serum-free formulation
- Animal component-free
- Supports T cell expansion and culture
- Designed for cell therapy workflows
- Promotes process consistency and reproducibility
- Suitable for scalable manufacturing strategies
- Supports standardized culture conditions
- Part of the PRIME-XV cell therapy media portfolio
Applications
- T cell culture
- T cell expansion
- Cell therapy development
- CAR-T research
- Immunotherapy research
- T cell manufacturing
- Process development
- Translational cell therapy workflows
- Cell and gene therapy research
